Correlation Between Opthea and Celldex Therapeutics
Can any of the company-specific risk be diversified away by investing in both Opthea and Celldex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and Celldex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opthea and Celldex Therapeutics, you can compare the effects of market volatilities on Opthea and Celldex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of Celldex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and Celldex Therapeutics.
Diversification Opportunities for Opthea and Celldex Therapeutics
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Opthea and Celldex is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and Celldex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celldex Therapeutics and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with Celldex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celldex Therapeutics has no effect on the direction of Opthea i.e., Opthea and Celldex Therapeutics go up and down completely randomly.
Pair Corralation between Opthea and Celldex Therapeutics
Considering the 90-day investment horizon Opthea is expected to generate 1.64 times more return on investment than Celldex Therapeutics. However, Opthea is 1.64 times more volatile than Celldex Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Celldex Therapeutics is currently generating about -0.16 per unit of risk. If you would invest 477.00 in Opthea on November 27, 2024 and sell it today you would earn a total of 13.00 from holding Opthea or generate 2.73% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Opthea vs. Celldex Therapeutics
Performance |
Timeline |
Opthea |
Celldex Therapeutics |
Opthea and Celldex Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Opthea and Celldex Therapeutics
The main advantage of trading using opposite Opthea and Celldex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, Celldex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celldex Therapeutics will offset losses from the drop in Celldex Therapeutics' long position.Opthea vs. Molecular Partners AG | Opthea vs. MediciNova | Opthea vs. Anebulo Pharmaceuticals | Opthea vs. Champions Oncology |
Celldex Therapeutics vs. Ideaya Biosciences | Celldex Therapeutics vs. AnaptysBio | Celldex Therapeutics vs. MeiraGTx Holdings PLC | Celldex Therapeutics vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |